pI: 7.162 |
Length (AA): 85 |
MW (Da): 9552 |
Paralog Number:
3
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 85 | 4y7u (A) | 1 | 84 | 35.00 | 0 | 0.97 | 1.4444 | -0.15 |
1 | 73 | 2v0h (A) | 6 | 82 | 32.00 | 0.029 | 0.73 | 1.08282 | 0.23 |
1 | 75 | 1jyk (A) | 6 | 76 | 41.00 | 0 | 1 | 1.34475 | -0.1 |
16 | 70 | 3tqd (A) | 8 | 64 | 28.00 | 0 | 0.76 | 0.955659 | -0.4 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127109)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G55590 | probable mannose-1-phosphate guanylyltransferase 2 |
Arabidopsis thaliana | AT4G30570 | Glucose-1-phosphate adenylyltransferase family protein |
Arabidopsis thaliana | AT2G39770 | GDP-mannose pyrophosphorylase/ mannose-1-pyrophosphatase |
Babesia bovis | BBOV_II006730 | mannose-1-phosphate guanyltransferase, putative |
Brugia malayi | Bm1_40495 | GDP-mannose pyrophosphorylase B |
Candida albicans | CaO19.6190 | GDP-mannose pyrophosphorylase similar to S. cerevisiae PSA1 (YDL055C) |
Caenorhabditis elegans | CELE_C42C1.5 | Protein TAG-335 |
Cryptosporidium hominis | Chro.20192 | GDP-mannose pyrophosphorylase (4N40) |
Cryptosporidium parvum | cgd2_1770 | mannose-1-phosphate guanylyltransferase |
Dictyostelium discoideum | DDB_G0287619 | GTP:alpha-D-mannose-1-phosphate guanylyltransferase |
Drosophila melanogaster | Dmel_CG1129 | CG1129 gene product from transcript CG1129-RE |
Echinococcus granulosus | EgrG_000980800 | mannose 1 phosphate guanyltransferase beta |
Echinococcus granulosus | EgrG_001172900 | mannose 1 phosphate guanyltransferase beta |
Echinococcus multilocularis | EmuJ_001172900 | mannose 1 phosphate guanyltransferase beta |
Echinococcus multilocularis | EmuJ_000980800 | mannose 1 phosphate guanyltransferase beta |
Homo sapiens | ENSG00000173540 | GDP-mannose pyrophosphorylase B |
Leishmania braziliensis | LbrM.23.0120 | GDP-mannose pyrophosphorylase |
Leishmania donovani | LdBPK_230120.1 | GDP-mannose pyrophosphorylase |
Leishmania infantum | LinJ.23.0120 | GDP-mannose pyrophosphorylase |
Leishmania major | LmjF.23.0110 | GDP-mannose pyrophosphorylase |
Leishmania mexicana | LmxM.23.0110 | mannose-1-phosphate guanyltransferase |
Loa Loa (eye worm) | LOAG_09793 | hypothetical protein |
Loa Loa (eye worm) | LOAG_13550 | GDP-mannose pyrophosphorylase B |
Loa Loa (eye worm) | LOAG_16056 | hypothetical protein |
Loa Loa (eye worm) | LOAG_05391 | GDP-mannose pyrophosphorylase B |
Mycobacterium leprae | ML0753 | Probable D-alpha-D-mannose-1-phosphate guanylyltransferase ManB (D-ALPHA-D-HEPTOSE-1-PHOSPHATE GUANYLYLTRANSFERASE) |
Mus musculus | ENSMUSG00000070284 | GDP-mannose pyrophosphorylase B |
Mycobacterium tuberculosis | Rv3264c | D-alpha-D-mannose-1-phosphate guanylyltransferase ManB (D-alpha-D-heptose-1-phosphate guanylyltransferase) |
Mycobacterium ulcerans | MUL_2610 | d-alpha-D-mannose-1-phosphate guanylyltransferase ManB |
Neospora caninum | NCLIV_028400 | Nucleotidyl transferase family protein, related |
Oryza sativa | 4332373 | Os03g0268400 |
Oryza sativa | 4327472 | Os01g0847200 |
Oryza sativa | 4345021 | Os08g0237200 |
Plasmodium berghei | PBANKA_1022300 | mannose-1-phosphate guanyltransferase, putative |
Plasmodium falciparum | PF3D7_1420900 | mannose-1-phosphate guanyltransferase, putative |
Plasmodium knowlesi | PKNH_1337100 | mannose-1-phosphate guanyltransferase, putative |
Plasmodium vivax | PVX_085435 | mannose-1-phosphate guanyltransferase, putative |
Plasmodium yoelii | PY05717 | GDP-mannose pyrophosphorylase |
Saccharomyces cerevisiae | YDL055C | mannose-1-phosphate guanylyltransferase |
Schistosoma japonicum | Sjp_0006520 | ko:K00971 mannose-1-phosphate guanylyltransferase [EC2.7.7.22], putative |
Schistosoma japonicum | Sjp_0091930 | Mannose-1-phosphate guanyltransferase beta, putative |
Schistosoma mansoni | Smp_000510 | gdp-mannose pyrophosphorylase b isoform 2 |
Schistosoma mansoni | Smp_028730 | glucosamine-1-phosphate N-acetyltransferase |
Schmidtea mediterranea | mk4.018074.00 | Mannose-1-phosphate guanyltransferase beta |
Schmidtea mediterranea | mk4.004902.07 | Mannose-1-phosphate guanyltransferase beta |
Schmidtea mediterranea | mk4.001359.06 | |
Schmidtea mediterranea | mk4.001359.04 | |
Schmidtea mediterranea | mk4.012886.00 | Mannose-1-phosphate guanyltransferase |
Schmidtea mediterranea | mk4.073271.00 | Mannose-1-phosphate guanyltransferase beta |
Schmidtea mediterranea | mk4.006750.01 | Mannose-1-phosphate guanyltransferase |
Schmidtea mediterranea | mk4.001359.02 | Mannose-1-phosphate guanyltransferase beta |
Trypanosoma brucei gambiense | Tbg972.8.1690 | mannose-1-phosphate guanyltransferase, putative |
Trypanosoma brucei | Tb927.8.2050 | GDP-mannose pyrophosphorylase |
Trypanosoma cruzi | TcCLB.510947.10 | GDP-mannose pyrophosphorylase |
Trypanosoma cruzi | TcCLB.503589.10 | GDP-mannose pyrophosphorylase |
Toxoplasma gondii | TGME49_257960 | GDP-D-mannose pyrophosphorylase |
Theileria parva | TP02_0639 | GDP-mannose pyrophosphorylase, putative |
Trichomonas vaginalis | TVAG_394720 | sugar-1-phosphate guanyl transferase, putative |
Trichomonas vaginalis | TVAG_178210 | glucose-1-phosphate thymidylyltransferase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.2050 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.2050 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.2050 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.8.2050 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C42C1.5 | Caenorhabditis elegans | adult lethal | wormbase |
CELE_C42C1.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C42C1.5 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C42C1.5 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_C42C1.5 | Caenorhabditis elegans | sterile | wormbase |
YDL055C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1022300 | Plasmodium berghei | Slow | plasmo |
TGME49_257960 | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.